Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ASA Gold and Precious Metals Ltd C.ASA


Primary Symbol: ASA

ASA Gold and Precious Metals Limited is a non-diversified, closed-end investment company. The Company's investment objective is long-term capital appreciation primarily through investing in companies engaged in the exploration for, development of projects or mining of precious metals and minerals. The Company invests approximately 80% of its total assets in common shares or securities convertible into common shares of companies engaged, directly or indirectly, in the exploration, mining or processing of gold, silver, platinum, diamonds or other precious minerals; held as bullion or other direct forms of gold, silver, platinum or other precious minerals; in instruments representing interests in gold, silver, platinum or other precious minerals, and/or in securities of investment companies, including exchange traded funds, or other securities. The Company’s investment adviser is Merk Investments LLC.


NYSE:ASA - Post by User

Comment by Gryphon1734on Oct 31, 2017 4:07pm
93 Views
Post# 26884157

RE:Health Canada License

RE:Health Canada LicenseAs I assume you know, Valens already holds a Health Canada Dealers License which was issued and announced on May 18th. Then, on May 30th, the company announced that they were  "expediting the acquisition of its own Licences to Produce (“LP”) and Licences to Sell (“LS”) under the revised Access to Cannabis for Medical Purposes Regulations (“ACMPR”) process, as a follow up to its recently awarded Controlled Drugs and Substances Dealer's Licence (“DL”)."
As I understand it now, that full aplication is in with Health Canada and the expectation is to have that granted early (likely the 1st quarter) of 2018.
Hope that helps :)
Bullboard Posts